Drug Discovery & Development | EU Committee Backs New Form of Roche Cancer Drug Drug Discovery & Development Roche announced that the EU Committee for Medicinal Products for Human Use (CHMP) recommended that the European Commission approve MabThera (rituximab) 1400mg solution for subcutaneous (SC) injection for the treatment of patients with common ... |
